Show simple item record

dc.contributor.authorHatton, Grace
dc.contributor.authorAlterio, Tommaso
dc.contributor.authorNobili, Valerio
dc.contributor.authorMann, Jake
dc.date.accessioned2018-08-20T12:30:02Z
dc.date.available2018-08-20T12:30:02Z
dc.date.issued2018-10
dc.identifier.issn1747-4124
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/278960
dc.description.abstractINTRODUCTION: Pediatric nonalcoholic fatty liver disease (NAFLD) is common disorder that has complex pathophysiology and unquantified clinical significance. Though there have been major advances in the field, there is much yet to be understood. Areas covered: PubMed/MEDLINE and Embase were searched for articles related to pediatric NAFLD and nonalcoholic steatohepatitis (NASH) between January 1998 and January 2018. The areas considered to be 'unmet needs' were the relationship between the intestinal microbiome and perinatal events, clinical event risk stratification, and mechanisms underlying portal inflammation. Expert commentary: In utero and ex utero factors have been associated with NAFLD and also with the intestinal microbiome, but it is not yet known how intestinal dysbiosis can be reversed and whether intervention in high-risk neonates could alter their propensity for the metabolic syndrome. Children with NAFLD are at increased risk of cardiovascular, diabetic, and hepatic diseases, but it is unclear how best to stratify children into appropriate risk groups for targeted interventions. Finally, the immune processes underlying pediatric NASH are thought to differ to those in adult NASH, yet the events surrounding activation of periportal lymphocytes are poorly understood. Deepening our understanding of these topics may lead to novel therapeutic targets.
dc.format.mediumPrint-Electronic
dc.languageeng
dc.publisherInforma UK Limited
dc.subjectHumans
dc.subjectCardiovascular Diseases
dc.subjectRisk Assessment
dc.subjectBiomedical Research
dc.subjectAdolescent
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectDysbiosis
dc.subjectNon-alcoholic Fatty Liver Disease
dc.subjectGastrointestinal Microbiome
dc.subjectMetabolic Syndrome
dc.subjectHost Microbial Interactions
dc.titleUnmet needs in pediatric NAFLD research: what do we need to prioritize for the future?
dc.typeArticle
prism.endingPage967
prism.issueIdentifier10
prism.publicationDate2018
prism.publicationNameExpert Rev Gastroenterol Hepatol
prism.startingPage961
prism.volume12
dc.identifier.doi10.17863/CAM.26342
dcterms.dateAccepted2018-08-14
rioxxterms.versionofrecord10.1080/17474124.2018.1512853
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-10
dc.contributor.orcidMann, Jake [0000-0002-4711-9215]
dc.identifier.eissn1747-4132
rioxxterms.typeJournal Article/Review
cam.issuedOnline2018-08-21
rioxxterms.freetoread.startdate2019-08-17


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record